{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T02:36:13Z","timestamp":1784342173599,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Inflammatory myofibroblastic tumors (IMTs) of the thyroid are extremely rare soft-tissue tumors. In the literature, IMTs are sometimes called plasma cell granulomas (PCGs) or inflammatory pseudotumors, which often causes ambiguity. To date, 17 cases of PCGs and five cases of thyroid IMTs have been reported. These cases reveal that IMTs of the thyroid are often negative for the anaplastic lymphoma kinase (<jats:italic>ALK<\/jats:italic>-1) gene. To provide further information on this rare lesion, we present a case of an ALK-1-positive thyroid IMT and a review of IMTs of the thyroid.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A 34-year-old Chinese woman presented with a painless neck mass that had persisted for over a month. Ultrasonography revealed a 4.28\u2009\u00d7\u20092.53\u2009cm<jats:sup>2<\/jats:sup>hypoechoic mass, in the left lobe of the thyroid gland. Serum levels of thyroglobulin and anti-thyroglobulin antibodies were high. Subsequently, left lobectomy was performed. Macroscopically, the lesion was a gray-brown nodular mass with a partial envelope. Histologically, two different lesion types were observed. The first lesion showed classic spindle cell proliferation, with spindle cells arranged in fascicles, accompanied by mature inflammatory cells. The other lesion showed a large number of infiltrating lymphocytes, with lymphoid follicles in the remaining thyroid gland, which was atrophic. Immunohistochemical staining showed that the spindle cells were negative for CK19, CyclinD1, Gelectin-3, EMA, CD34, S100, Bcl-2, and STAT-6, but strongly positive for ALK-1, vimentin, and TTF1. CK was focally expressed, and the Ki-67 index was 5%. A diagnosis of IMT was proposed according to immunohistochemical findings and morphology. Hashimoto\u2019s thyroiditis was confirmed according to serum levels of thyroglobulin and anti-thyroglobulin antibodies and morphology. The patient did not receive adjuvant therapy. She remained alive without disease recurrence for 10\u2009months after lobectomy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>IMTs should be considered in the diagnosis when spindle cell proliferation accompanied by mature inflammatory cells is observed, spindle cells are mildly atypical, and myofibroblast differentiation is present in the thyroid. A uniform diagnostic term is crucial to avoid ambiguity. Clinicians and pathologists should be aware of the necessity for long-term follow-up, especially in ALK-positive cases. The therapeutic potential of ALK-1 positivity should be explored further.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13000-020-00966-4","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T12:03:47Z","timestamp":1589889827000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["ALK-1-positive inflammatory myofibroblastic tumor of the thyroid complicated by Hashimoto\u2019s thyroiditis: report of a rare case and a literature review"],"prefix":"10.1186","volume":"15","author":[{"given":"Cheng-fang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-long","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-jia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-zhong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,19]]},"reference":[{"key":"966_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2559.2005.02284.x","volume":"48","author":"CDM Fletcher","year":"2006","unstructured":"Fletcher CDM. The evolving classification of soft tissue tumours: an update based on the new WHO classification. Histopathology. 2006;48:3\u201312.","journal-title":"Histopathology"},{"key":"966_CR2","first-page":"288","volume-title":"Borderline and malignant fibroblastic\/myofibroblastic tumors. Enzinger and Weiss's Soft Tissue Tumors","author":"JRFA Goldblum","year":"2014","unstructured":"Goldblum JRFA, Weiss SW. Borderline and malignant fibroblastic\/myofibroblastic tumors. Enzinger and Weiss's Soft Tissue Tumors. 6th ed. Philadelphia: Saunders\/Elsevier; 2014. p. 288\u2013340.","edition":"6"},{"key":"966_CR3","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1097\/00000478-200111000-00003","volume":"25","author":"JR Cook","year":"2001","unstructured":"Cook JR, Dehner LP, Collins MH, Ma Z, Morris SW, Coffin CM, Hill DA. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Am J Surg Pathol. 2001;25:1364\u201371.","journal-title":"Am J Surg Pathol"},{"key":"966_CR4","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/PAS.0000000000000404","volume":"39","author":"CR Antonescu","year":"2015","unstructured":"Antonescu CR, Suurmeijer AJH, Zhang L, Sung Y-S, Jungbluth AA, Travis WD, Al-Ahmadie H, Fletcher CDM, Alaggio R. Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement. Am J Surg Pathol. 2015;39:957\u201367.","journal-title":"Am J Surg Pathol"},{"key":"966_CR5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1158\/2159-8290.CD-14-0377","volume":"4","author":"CM Lovly","year":"2014","unstructured":"Lovly CM, Gupta A, Lipson D, Otto G, Brennan T, Chung CT, Borinstein SC, Ross JS, Stephens PJ, Miller VA, Coffin CM. Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions. Cancer Disc. 2014;4:889\u201395.","journal-title":"Cancer Disc"},{"key":"966_CR6","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/dc.23950","volume":"46","author":"M Ghosh","year":"2018","unstructured":"Ghosh M, Islam N, Saha H, Mukhopadhyay M, Datta C, Saha K, Chatterjee U. Cytodiagnosis of inflammatory myofibroblastic tumor: a report of three cases in infants. Diagn Cytopathol. 2018;46:776\u201381.","journal-title":"Diagn Cytopathol"},{"key":"966_CR7","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.prp.2014.03.011","volume":"210","author":"AM Buccoliero","year":"2014","unstructured":"Buccoliero AM, Ghionzoli M, Castiglione F, Paglierani M, Baroni G, Messineo A, Taddei GL. Inflammatory myofibroblastic tumor: clinical, morphological, immunohistochemical and molecular features of a pediatric case. Pathol Res Pract. 2014;210:1152\u20135.","journal-title":"Pathol Res Pract"},{"key":"966_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0002-9440(10)61711-7","volume":"159","author":"JA Bridge","year":"2001","unstructured":"Bridge JA, Kanamori M, Ma Z, Pickering D, Hill DA, Lydiatt W, Lui MY, Colleoni GW, Antonescu CR, Ladanyi M, Morris SW. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. Am J Pathol. 2001;159:411\u20135.","journal-title":"Am J Pathol"},{"key":"966_CR9","doi-asserted-by":"publisher","unstructured":"Lopez-Nunez O, John I, Panasiti RN, Ranganathan S, Santoro L, Gr\u00e9laud D, Wu T, Buccoliero AM, Casanova M, Alaggio R, Surrey LF. Infantile inflammatory myofibroblastic tumors: clinicopathological and molecular characterization of 12 cases. Modern Pathol. 2019. https:\/\/doi.org\/10.1038\/s41379-41019-40406-41376.","DOI":"10.1038\/s41379-41019-40406-41376"},{"key":"966_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1365-2559.1993.tb00508.x","volume":"23","author":"PP Anthony","year":"1993","unstructured":"Anthony PP. Inflammatory pseudotumour (plasma cell granuloma) of lung, liver and other organs. Histopathology. 1993;23:501\u20133.","journal-title":"Histopathology"},{"key":"966_CR11","first-page":"3673","volume":"7","author":"CF Li","year":"2014","unstructured":"Li CF, Liu CX, Li BC, Shen YY, Cui XB, Liu W, Dong HC, Pang LJ, Liang WH, Li F. Recurrent inflammatory myofibroblastic tumors harboring PIK3CA and KIT mutations. Int J Clin Exp Pathol. 2014;7:3673\u201383.","journal-title":"Int J Clin Exp Pathol"},{"key":"966_CR12","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00428-015-1842-4","volume":"467","author":"K Ludwig","year":"2015","unstructured":"Ludwig K, Alaggio R, Dall'Igna P, Lazzari E, d'Amore ESG, Chou PM. Omental mesenteric myxoid hamartoma, a subtype of inflammatory myofibroblastic tumor? Considerations based on the histopathological evaluation of four cases. Virchows Archiv. 2015;467:741\u20137.","journal-title":"Virchows Archiv"},{"key":"966_CR13","doi-asserted-by":"publisher","first-page":"e8485","DOI":"10.1097\/MD.0000000000008485","volume":"96","author":"J Duan","year":"2017","unstructured":"Duan J, Wang Y. A case report of recurrent thyroid inflammatory myofibroblastic tumor and its metastasis in soft tissue. Medicine. 2017;96:e8485.","journal-title":"Medicine"},{"key":"966_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/1097-0142(197301)31:1<191::AID-CNCR2820310127>3.0.CO;2-D","volume":"31","author":"M Bahadori","year":"1973","unstructured":"Bahadori M, Liebow AA. Plasma cell granulomas of the lung. Cancer. 1973;31:191\u2013208.","journal-title":"Cancer"},{"key":"966_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/00055735-200212000-00001","volume":"13","author":"D Jacobs","year":"2002","unstructured":"Jacobs D, Galetta S. Diagnosis and management of orbital pseudotumor. Curr Opin Ophthalmol. 2002;13:347\u201351.","journal-title":"Curr Opin Ophthalmol"},{"key":"966_CR16","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1258\/0022215011908234","volume":"115","author":"C Ruaux","year":"2001","unstructured":"Ruaux C, Noret P, Godey B. Inflammatory pseudotumour of the nasal cavity and sinuses. J Laryngol Otol. 2001;115:563\u20136.","journal-title":"J Laryngol Otol"},{"key":"966_CR17","first-page":"856","volume":"115","author":"C Ereno","year":"2001","unstructured":"Ereno C, Lopez JI, Grande J, Santaolalla F, Bilbao FJ. Inflammatory myofibroblastic tumour of the larynx. J Laryngol Otol. 2001;115:856\u20138.","journal-title":"J Laryngol Otol"},{"key":"966_CR18","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/00000478-199508000-00001","volume":"19","author":"CM Coffin","year":"1995","unstructured":"Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol. 1995;19:859\u201372.","journal-title":"Am J Surg Pathol"},{"key":"966_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.oraloncology.2011.09.004","volume":"48","author":"HS Ong","year":"2012","unstructured":"Ong HS, Ji T, Zhang CP, Li J, Wang LZ, Li RR, Sun J, Ma CY. Head and neck inflammatory myofibroblastic tumor (IMT): evaluation of clinicopathologic and prognostic features. Oral Oncol. 2012;48:141\u20138.","journal-title":"Oral Oncol"},{"key":"966_CR20","first-page":"121","volume-title":"Inflammatory myofibroblastic tumor. World Health Organization Classification of Tumours; vol 7","author":"ACC Borezuk","year":"2015","unstructured":"Borezuk ACC, Fletcher CDM. Inflammatory myofibroblastic tumor. World Health Organization Classification of Tumours; vol 7. Lyon: IARC Press; 2015. p. 121\u20132."},{"key":"966_CR21","first-page":"Ed05","volume":"10","author":"S Marylilly","year":"2016","unstructured":"Marylilly S, Subachitra T, Ramya V. Inflammatory Myofibroblastic Tumour of Thyroid with its Prominent Spindle Cell Pattern: A Rare Case Report. J Clin Diagn Res. 2016;10:Ed05\u20137.","journal-title":"J Clin Diagn Res"},{"key":"966_CR22","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00405-008-0740-7","volume":"266","author":"M Trimeche","year":"2009","unstructured":"Trimeche M, Ziadi S, Mestiri S, Mani R, Sriha B, Bouzouita K, Mokni M, Korbi S. Inflammatory myofibroblastic tumor of the thyroid in its sclerosing subtype: the first case report. Eur Arch Otorhinolaryngol. 2009;266:763\u20136.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"966_CR23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4132\/KoreanJPathol.2014.48.4.319","volume":"48","author":"HJ Kim","year":"2014","unstructured":"Kim HJ, Na JI, Lee JS, Cho DH, Cho JS. Inflammatory myofibroblastic tumor of the thyroid gland: a brief case report. Korean J Pathol. 2014;48:319\u201322.","journal-title":"Korean J Pathol"},{"key":"966_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s12022-009-9080-4","volume":"20","author":"M Kojima","year":"2009","unstructured":"Kojima M, Suzuki M, Shimizu K, Masawa N. Inflammatory pseudotumor of the thyroid gland showing prominent fibrohistiocytic proliferation. A case report. Endocr Pathol. 2009;20:186\u201390.","journal-title":"Endocr Pathol"},{"key":"966_CR25","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/modpathol.3880352","volume":"14","author":"CM Coffin","year":"2001","unstructured":"Coffin CM, Patel A, Perkins S, Elenitoba-Johnson KS, Perlman E, Griffin CA. ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol. 2001;14:569\u201376.","journal-title":"Mod Pathol"},{"key":"966_CR26","doi-asserted-by":"publisher","first-page":"998","DOI":"10.5858\/arpa.2017-0068-RS","volume":"142","author":"PA Patil","year":"2018","unstructured":"Patil PA, DeLellis RA. Plasma cell granuloma of the thyroid: review of an uncommon entity. Arch Pathol Lab Med. 2018;142:998\u20131005.","journal-title":"Arch Pathol Lab Med"},{"key":"966_CR27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/1477-7819-9-133","volume":"9","author":"T Goto","year":"2011","unstructured":"Goto T, Akanabe K, Maeshima A, Kato R. Surgery for recurrent inflammatory pseudotumor of the lung. World J Surgical Oncol. 2011;9:133.","journal-title":"World J Surgical Oncol"},{"key":"966_CR28","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/cncr.24684","volume":"116","author":"R Alaggio","year":"2010","unstructured":"Alaggio R, Cecchetto G, Bisogno G, Gambini C, Calabr\u00f2 ML, Inserra A, Boldrini R, De Salvo GL, d'Amore ES G, Dall'igna P. Inflammatory myofibroblastic tumors in childhood: a report from the Italian cooperative group studies. Cancer. 2010;116:216\u201326.","journal-title":"Cancer"},{"key":"966_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s11604-012-0065-8","volume":"30","author":"SM Prabhu","year":"2012","unstructured":"Prabhu SM, Choudhury SR, Solanki RS, Shetty GS. Multifocal intrathoracic inflammatory myofibroblastic tumour in children. Jpn J Radiol. 2012;30:453\u20137.","journal-title":"Jpn J Radiol"},{"key":"966_CR30","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1510\/icvts.2009.219089","volume":"10","author":"K Ochs","year":"2010","unstructured":"Ochs K, Hoksch B, Frey U, Schmid RA. Inflammatory myofibroblastic tumour of the lung in a five-year-old girl. Interact Cardiovasc Thorac Surg. 2010;10:805\u20136.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"966_CR31","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/01.pas.0000213393.57322.c7","volume":"31","author":"CM Coffin","year":"2007","unstructured":"Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007;31:509\u201320.","journal-title":"Am J Surg Pathol"},{"key":"966_CR32","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/ajh.25043","volume":"93","author":"C Gambacorti-Passerini","year":"2018","unstructured":"Gambacorti-Passerini C, Orlov S, Zhang L, Braiteh F, Huang H, Esaki T, Horibe K, Ahn JS, Beck JT, Edenfield WJ, Shi Y, Taylor M, Tamura K, Van Tine BA, Wu SJ, Paolini J, Selaru P, Kim TM. Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): a phase 1b open-label study. Am J Hematol. 2018;93:607\u201314.","journal-title":"Am J Hematol"},{"key":"966_CR33","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.2169\/internalmedicine.1640-18","volume":"58","author":"M Ogata","year":"2019","unstructured":"Ogata M, Hatachi Y, Ogata T, Satake H, Imai Y, Yasui H. Effectiveness of Crizotinib for Inflammatory Myofibroblastic Tumor with ALK mutation. Int Med (Tokyo, Japan). 2019;58:1029\u201332.","journal-title":"Int Med (Tokyo, Japan)"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-020-00966-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-020-00966-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-020-00966-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:41:48Z","timestamp":1722904908000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-020-00966-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,19]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["966"],"URL":"https:\/\/doi.org\/10.1186\/s13000-020-00966-4","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,19]]},"assertion":[{"value":"10 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}